Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma

Expert Review of Precision Medicine and Drug Development · Published 2024-03-18 · DOI 10.1080/23808993.2024.2330422

Authors being retrieved — see the publisher record. https://doi.org/10.1080/23808993.2024.2330422

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2024

Related articles